Toripalimab Plus Bevacizumab and Chemotherapy as Neoadjuvant Therapy in Advanced MSI-H or dMMR Colorectal Cancer
Clinical trial NCT04988191 · UNKNOWN
Trial details
- NCT number
- NCT04988191
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-24
- Primary completion
- 2023-06-24
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.